Diagnostic Menu Expansion
SDIX offers various services in the antibody and assay field to expand diagnostic menus on our client’s automated platforms. A leading principle behind our offering is to guide our clients from early assay development to late production or marketing stage without losing the connection between development and production phases.
Antibody development – multiple antibodies (mAb and pAb)
There are various factors that directly influence performance of an immunoassay - the most critical of which is choosing or developing the right antibodies. It’s especially important in clinical assays, where assays are expected to perform to an exact standard, from day of launch to product termination date. For this reason, antibody development demands primary attention. Numerous factors need to be addressed – from what types of antibodies are to be used, to which epitope should be bound, to what should be the match paired antibody.
SDIX’s deep knowledge in the antigen-antibody domain combined with 20 years experience in immuno-assays has helped us create best-in-class reagent development services that address all the above compelling needs of clinical assay customers.
SDIX develops immuno-reagents for:
- Clinical Immunoassay
-
Immunoturbidimetry
- Nephelometry
- Flow cytometry
- Point of Care Diagnostics
- Companion Diagnostics
Reagents for Clinical Assays
